Skip to playerSkip to main content
  • 15 hours ago
Transcript
00:00When it comes to the U.S. market, you've been losing share to your rival, Eli Lilly, for a couple years now.
00:05But with this approval, you have an important first mover advantage when it comes to oral GLP-1s.
00:12Given that you expect to start selling the pill version of Wegovi in January, whereas Eli Lilly isn't due on the market until March,
00:18how do you plan to make the most of this head start?
00:21Thanks very much for having me, Katie.
00:23As they say, Christmas comes early, so I'm super excited, of course, to be here announcing the Wegovi pill.
00:31As you say, this is really going to be super exciting for the millions of patients that have been waiting to get their hands on a GLP-1 pill.
00:41And for the first time, we are having a pill that has an efficacy of some 17% if you take the pill regularly,
00:48and one in three people are going to actually reduce up to 20% weight loss.
00:53I think that data speaks for itself, and we are super excited, of course, to be the first to the market,
00:59and we're going to go all in trying to make this a huge success.
01:04Well, moving forward, I mean, beyond just these first few months, after Eli Lilly does have their pill on the market,
01:11how do you plan to compete? What is your strategy there, given my understanding is that there's likely going to be no restrictions
01:18when it comes to food, when it comes to drinks, around Lilly's version?
01:23Yeah, so as I mentioned, there are no other phase three trials of oral GLP-1 that has shown this level of efficacy.
01:31This means that for the first time ever, people do not have compromise
01:35between either taking an efficacious injection or a convenient pill.
01:42For the first time ever, you have the same efficacy of 17% in injection or a pill.
01:48You can take it on a daily basis as a pill or a weekly injection,
01:51and that, I think, is the key selling point with Vigo v. pill.
01:55We also have more than 10 years of, of course, experience with regards to safety data and what have you.
02:03That's why it's called the Vigo v. pill, which means that this pill is not only going to reduce your weight,
02:09it also has protection for your cardiovascular systems.
02:12So this is a phenomenal pill, second to none, I would say, and we are very ready to compete with it.
Be the first to comment
Add your comment

Recommended